Corteva, Inc. $CTVA Stake Lifted by Banque Cantonale Vaudoise
π Banque Cantonale Vaudoise lifted its CTVA stake by 305.6% in Q1, acquiring an additional 13,797 shares to hold a total of 18,311 shares.
π° Multiple institutional investors including JPL Wealth Management and Bank of Jackson Hole Trust established new positions valued between $25,000 and $30,000 in Q3 and Q4.
π Deutsche Bank raised its price target to $100.00, while Mizuho and Royal Bank of Canada also increased targets with 'outperform' ratings.
π Corteva beat Q1 earnings estimates significantly, reporting $1.50 EPS compared to the consensus of $1.18.
π΅ Revenue reached $4.91 billion in the quarter, representing an 11% year-over-year increase over analyst expectations of $4.64 billion.
π The stock trades at a PE ratio of 48.59 with a market capitalization of $55.24 billion and a beta of 0.57.
π° A quarterly dividend of $0.18 per share was paid on June 15th, resulting in an annualized yield of 0.9%.
π‘οΈ The company maintains a strong balance sheet with a debt-to-equity ratio of 0.07 and a current ratio of 1.47.
π± Corteva focuses on seed genetics and crop protection, having separated from DowDuPont in mid-2019 to become an independent global agriculture company.
π Analysts forecast FY 2026 EPS between $3.45 and $3.70, with the current year consensus estimate at $3.72.
- Banque Cantonale Vaudoise increased its stake by 305.6% in Q1, signaling strong institutional confidence in the company's long-term prospects.
- Deutsche Bank raised its price target to $100.00, Mizuho set a target of $94.00 with an 'outperform' rating, and Royal Bank of Canada adjusted its target to $97.00.
- Corteva reported EPS of $1.50, significantly beating the consensus estimate of $1.18 by $0.32.
- Revenue of $4.91 billion exceeded analyst expectations of $4.64 billion, driven by an 11% year-over-year growth rate.
- The company maintains a very low debt-to-equity ratio of 0.07 and a current ratio of 1.47, indicating strong liquidity and financial stability.
- Fourteen analysts have issued Buy ratings on the stock, contributing to a consensus 'Moderate Buy' rating with an average target price of $88.81.